TY - JOUR TI - In vivo HSC gene therapy using a bi-modular HDAd5/35++ vector cures Sickle Cell Disease in a mouse model. AU - Li, Chang AU - Wang, Hongjie AU - Georgakopoulou, Aphrodite AU - Gil, Sucheol AU - Yannaki, Evangelia AU - Lieber, André T2 - Molecular Therapy DA - 2020/09/05/ PY - 2020 DO - 10.1016/j.ymthe.2020.09.001 DP - www.cell.com VL - 0 IS - 0 J2 - Molecular Therapy LA - English SN - 1525-0016, 1525-0024 UR - https://www.cell.com/molecular-therapy-family/molecular-therapy/abstract/S1525-0016(20)30458-5 Y2 - 2020/09/09/17:28:16 ER -